GSK plc (NYSE:GSK) finished Thursday with an addition of $0.24 to close at $30.01, an upside of 0.81 percent. An average of 6,928,720 shares of common stock have been traded in the last five days. There was a fall of -$1.01 in the past week, and it reached a new high 24 times over the past 12 months. The last 20 days have seen an average of 6,423,910 shares traded, while the 50-day average volume stands at 6,839,592.
GSK stock has decreased by -11.03% in the last month. The company shares reached their 1-month lowest point of $29.53 on 09/22/22. With the stock rallying to its 52-week high on 04/11/22, shares of the company touched a low of $29.73 and a high of $47.82 in 52 weeks. It has reached a new high 9 times so far this year and lost -33.15% or -$14.09 in price. In spite of this, the price is down -37.24% from the 52-week high.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
GSK plc (GSK) has a trailing price-to-earnings (P/E) ratio of 11.91. The stock’s beta is 0.64. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 1.63, the price-to-book (PB) ratio at 2.57, and the price-to-cash flow ratio at 10.16.
The company has a payout ratio of 27.70%. The company’s most recent quarterly dividend payment was $0.3830 a share, representing a up of 9.55% from $0.3496 last year. Its latest increase dividend $0.0334 reported on Wednesday July 27 2022.
The quick ratio of GSK plc for the three months ended June 29 was 1.30, and the current ratio was 1.40, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 1.15 and a total debt to equity ratio of 1.35 for the quarter ending June 29. Its gross profit as reported stood at $30.95 billion compared to revenue of $46.91 billion.
For the three-month period that ended June 29, GSK plc had -$921.0 million in total debt. In the quarter under review, the net income was down than the previous quarter. The company posted a net income of $4.38 billion in the quarter, while revenues were shrunk -31.11%. The analyst consensus anticipated GSK plc’s latest quarter earnings to come in at $0.73 per share, but it turned out to be $0.87, a 19.20% surprise. For the quarter, EBITDA amounted to $2.09 billion.
From a technical analysis perspective, let’s take a brief look at GSK plc (GSK) price momentum. RSI 9-day as of the close on 22 September was 22.45%, suggesting the stock is oversold, with historical volatility in this time frame at 19.98%.
As of today, GSK’s price is $30.38 -3.26% or -$1.01 from its 5-day moving average. GSK is currently trading -10.50% lower than its 20-day SMA and -33.72% lower than its 100-day SMA. However, the stock’s current price level is -26.66% below the SMA50 and -28.14% below the SMA200.
The stochastic %K and %D were 8.11% and 8.45%, respectively, and the average true range (ATR) was 0.62. With the 14-day stochastic at 14.16% and the average true range at 0.67, the RSI (14) stands at 22.93%. The stock has reached -0.82 on the 9-day MACD Oscillator while the 14-day reading was at -1.08.
Credit Suisse upgraded GSK plc (NYSE: GSK) to a a Neutral rating in its most recent analyst report. Previously, the stock was rated as an Underperform. The consensus rating for GSK plc (GSK) among analysts is Overweight. According to current brokerage recommendations, 0 brokerage firms advise that investors sell GSK, while 15 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 7 others rate it as a “buy”.
What is GSK’s price target for the next 12 months?
Analysts predict a range of price targets between $33.12 and $59.54, with a median target of $40.60. Taking a look at these predictions, the average price target given by analysts for GSK plc (GSK) stock is $41.51.